Arrowhead Research Raises $60M In PIPE

Pasadena-based Arrowhead Research said this morning that it has raised $60M in a private offering, from RA Capital Management, LLC, plus its other existing institutional investors. The biopharmaceuticals firm, which is developing targeted RNAi therapeutics, said the funding will go to fund two new pharmaceuticals candidates through clinical proof of concet, plus to advance its pre-clinical pipeline.